The following is a list of common questions related to Parallax Medical, vertebroplasty and ArthroCare Spine.
What is the background on Parallax?
What is ArthroCare Spine’s mission for the Parallax product line?
What does the Parallax Product line consist of?
Are vertebroplasty or bone biopsy procedures covered by HMOs or Medicare?
Which physicians are using Parallax devices?
What research is ArthroCare Spine involved in, as it relates to the Parallax product line?
Parallax-Medical began in 1997 as an innovative start-up based in Santa Cruz, California. The company’s dynamic team of professionals including leaders in the field of minimally invasive spine procedures created the now well-recognized product line for percutaneous injection of bone cement, bone access and bone augmentation.
Parallax was the first company in the world to develop a full line of products exclusively for the percutaneous injection of bone cement, bone access and bone augmentation. Over the years, the company formed solid relationships with key opinion leaders and practitioners, allowing Parallax to develop the integrated product-based solutions physicians require in order to treat patients safely and effectively.
Parallax-Medical was acquired in 2004 by ArthroCare Corp., which has further supported the company’s progressive reputation as a leader in the industry with new products, sales support, practice development and patient outreach programs.
We are dedicated to creating exceptional products that are safe, effective and exceed customer expectations and help drive innovation within the medicine.
The company's product lines include disposable and implantable devices and materials for percutaneous injection of bone cement, opacification materials, polymethylmethacrylate (PMMA) for cranioplasty, bone and vertebral body biopsy needles, and patient preparation.
Bone Biopsy
Bone Biopsy is a covered service for Medicare beneficiaries in many states when medically necessary and billed with the appropriate CPT code. Centers for Medicare & Medicaid Services (CMS) continuously reviews its coverage policy for bone biopsy, based on advances in the technology, as well as evidence available on medical effectiveness for selected indications. To confirm coverage policy inclusions and restrictions, consult Medicare national coverage determinations and/or your local Medicare contractor.
Private insurance health plan members may be eligible under plan guidelines for Bone Biopsy. Check with the individual payer to determine conditions for medical necessity, specific contraindications to the procedure and coverage details.
Vertebroplasty
Percutaneous Vertebroplasty is a covered service for Medicare beneficiaries in many states when medically necessary. Centers for Medicare & Medicaid Services (CMS) continuously reviews its coverage policy for Percutaneous Vertebroplasty based on advances in the technology, as well as evidence available on medical effectiveness for selected indications. To confirm coverage policy inclusions and restrictions, consult Medicare national coverage determinations and/or your local Medicare contractor.
Private insurance health plan members may be eligible under plan guidelines for Percutaneous Vertebroplasty. Check with the individual payer to determine conditions for medical necessity, specific contraindications to the procedure and coverage details.
ArthroCare is performing research in the field of vertebroplasty, tumor treatment, and other areas to better help patients live their lives. We are committed to providing high-quality, physician-driven products for the treatment of symptoms resulting from osteoporosis, metastases, and hemangiomas that support procedures from start to finish.
Future product offerings are developed with talented professionals who are committed to producing solutions for minimally invasive, and cost-effective techniques for physicians.
